Chemical Structure : MIPO
Catalog No.: PC-27195Not For Human Use, Lab Use Only.
MIPO is a pharmacological small-molecule NEK9 inhibitor with SPR KD of 7.72 uM, inhibits viability of Huh-7 and Hep3b cells with IC50 of 18.8 uM and 19.7 uM.
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
MIPO is a pharmacological small-molecule NEK9 inhibitor with SPR KD of 7.72 uM, inhibits viability of Huh-7 and Hep3b cells with IC50 of 18.8 uM and 19.7 uM.
MIPO reduces NEK9 mRNA and protein levels in Huh-7 and Hep3b cells, NEK9 overexpression partially rescued the inhibitory effects of MIPO, but not NEK2 or NEK6.
MIPO suppresses NEK9-driven tumour growth and restore antitumour immunity in vivo, restores CD8+ T cell antitumour activity.
Combining MIPO with PD-L1 blocker CA-170 synergistically enhances antitumour immunity in HCC.
| M.Wt | 392.52 | |
| Formula | C22H24N4OS | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
1. Lu G, et al. Gut. 2026 Jun 25:gutjnl-2026-338449.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright